JakAVI
JakAVI Products are primarily used for
Chronic idiopathic myelofibrosis, Polycythemia vera
About JakAVI Products
Uses of JakAVI Products
Ruxolitinib is used in the treatment of chronic idiopathic myelofibrosis and Polycythemia vera.
JakAVI Products side effects
Common
Side Effects of JakAVI are Anemia (low number of red blood cells), Low blood platelets, Dizziness, Infection, Fatigue, Decreased white blood cell count (neutrophils), Increased alanine aminotransferase, Bruising, Headache.
How JakAVI Products work
Ruxolitinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Patient Concerns about JakAVI Products
Frequently asked questions about JakAVI Products
Frequently asked questions about Ruxolitinib
Q. What is JakAVI 15mg Tablet used for?
JakAVI 15mg Tablet is prescribed to treat certain blood disorders such as myelofibrosis and polycythemia vera. It may also be used in graft-versus-host disease (in individuals aged 12 years and older). It works by reducing abnormal blood cell activity and easing symptoms such as an enlarged spleen, night sweats, and itching.
Q. Who should not take JakAVI 15mg Tablet?
There are no absolute contraindications listed, but JakAVI 15mg Tablet should not be used in individuals with uncontrolled infections or very low blood counts unless a doctor determines that the benefits outweigh the risks. Always consult your doctor before starting this medicine.
Q. Can JakAVI 15mg Tablet increase the risk of infections?
Yes. JakAVI 15mg Tablet can weaken your immune system and increase the risk of serious infections, including tuberculosis, shingles, and bacterial or viral illnesses. Report any fever, cough, painful skin rash, or unusual symptoms to your doctor immediately.
Q. Can stopping JakAVI 15mg Tablet suddenly be dangerous?
Yes. Stopping JakAVI 15mg Tablet suddenly may cause your symptoms—such as spleen pain or blood abnormalities—to return quickly or worsen. Do not discontinue this medicine on your own. Your doctor may reduce the dose gradually if needed.
Q. Can JakAVI 15mg Tablet cause low blood counts?
JakAVI 15mg Tablet may cause anemia (low red blood cells), thrombocytopenia (low platelets), or neutropenia (low white blood cells). These conditions can increase the risk of bleeding, fatigue, or infections. Your doctor will monitor your blood counts regularly during treatment.
Q. Does JakAVI 15mg Tablet increase the risk of skin cancer?
Yes. JakAVI 15mg Tablet may increase the risk of non-melanoma skin cancers such as basal cell carcinoma or squamous cell carcinoma. Regular skin examinations and sun protection are recommended while using this medicine.
Q. Can JakAVI 15mg Tablet affect cholesterol levels?
JakAVI 15mg Tablet may raise cholesterol levels. Your doctor will monitor your lipid profile during treatment and may prescribe medication if needed to manage it.
Q. Can JakAVI 15mg Tablet cause blood clots?
Yes. Some individuals taking JakAVI 15mg Tablet may develop blood clots in the veins or arteries. If you experience sudden leg pain, swelling, chest pain, or difficulty breathing, seek medical attention immediately.
Q. Does JakAVI 15mg Tablet increase the chance of other cancers?
Yes, JakAVI 15mg Tablet may increase the risk of developing secondary cancers, especially in people who currently smoke or have smoked in the past. Your doctor will monitor you for signs of new malignancies during long-term treatment.
Products for JakAVI
JakAVI 15mg Tablet
strip of 14 tablets
MRP
₹53013.39
JakAVI 10mg Tablet
strip of 10 tablets
MRP
₹43214
JakAVI 5mg Tablet
strip of 10 tablets
MRP
₹24346
JakAVI 20mg Tablet
strip of 10 tablets
MRP
₹52980
JakAVI 15mg Tablet
strip of 10 tablets
MRP
₹47193